Latest news
Loading news…
Celadon Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. London, England, United Kingdom Founded 2018 11-50 employees For Profit
Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- CEL
- Exchange
- LSE - London Stock Exchange
- IPO date
- Oct 19, 2018
- Delisted
- Mar 29, 2022
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 10
- IT spend
- $15K
Company Info
- Founded
- 2018
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 46
- HQ
- London, England, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Oct 19, 2018
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- 1.2
- Last leadership hire
- Mar 29, 2025
4
professional contacts at Celadon Pharmaceuticals
Contact execs at Celadon Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Celadon Pharmaceuticals
Loading news…
FAQs about Celadon Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.